Getting a myelodysplastic syndrome (MDS) diagnosis can be overwhelming and often results in more questions than answers. Many patients can relate to the experience of getting home from their diagnosis appointment and not being able to remember much past the words, “You have cancer”.
In this patient webinar held on May 8th, 2024, we were privileged to have Dr. Justin Taylor, a renowned MDS specialist from the Sylvester Comprehensive Cancer Center. Dr. Taylor, with his vast experience and expertise, guided our high-risk MDS (HR-MDS) community through the intricacies of an MDS diagnosis, the factors that determine its risk level, and the decision-making process for treatments. He also discussed the current treatment options available and shared his enthusiasm about promising treatments under study.
During the Q&A session, Dr. Tylor answered the following questions:
If you have been diagnosed with HR-MDS, watch the full recording to get a thorough overview of what HR-MDS is and what options you have available to you.
If you're eager to delve deeper into your MDS diagnosis, we highly recommend HealthTree University for MDS. This free, online video education series is taught by top MDS specialists from across the US, ensuring you have access to the most comprehensive and up-to-date information. Updated several times a year, HealthTree University for MDS covers all aspects of your diagnosis in an easy-to-understand format.
Start learning now; click here to get started!
Getting a myelodysplastic syndrome (MDS) diagnosis can be overwhelming and often results in more questions than answers. Many patients can relate to the experience of getting home from their diagnosis appointment and not being able to remember much past the words, “You have cancer”.
In this patient webinar held on May 8th, 2024, we were privileged to have Dr. Justin Taylor, a renowned MDS specialist from the Sylvester Comprehensive Cancer Center. Dr. Taylor, with his vast experience and expertise, guided our high-risk MDS (HR-MDS) community through the intricacies of an MDS diagnosis, the factors that determine its risk level, and the decision-making process for treatments. He also discussed the current treatment options available and shared his enthusiasm about promising treatments under study.
During the Q&A session, Dr. Tylor answered the following questions:
If you have been diagnosed with HR-MDS, watch the full recording to get a thorough overview of what HR-MDS is and what options you have available to you.
If you're eager to delve deeper into your MDS diagnosis, we highly recommend HealthTree University for MDS. This free, online video education series is taught by top MDS specialists from across the US, ensuring you have access to the most comprehensive and up-to-date information. Updated several times a year, HealthTree University for MDS covers all aspects of your diagnosis in an easy-to-understand format.
Start learning now; click here to get started!
about the author
Mary Arnett
Mary joined HealthTree in 2022. She works as the AML/MDS Community & Education Manager. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't working, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.